Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Guérin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45% rate of recurrence and 17% of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.

Original languageEnglish
Title of host publicationBladder Cancer
PublisherElsevier Inc.
Pages187-199
Number of pages13
ISBN (Electronic)9780128099407
ISBN (Print)9780128099391
DOIs
Publication statusPublished - 2017 Dec 14

Fingerprint

Urinary Bladder Neoplasms
Recurrence
Bacillus
Carcinoma in Situ
Research
Neoplasms
Therapeutics

Keywords

  • Nonmuscle invasive bladder cancer
  • Progression
  • Recurrence
  • Risk factors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer. / Park, Jae Young.

Bladder Cancer. Elsevier Inc., 2017. p. 187-199.

Research output: Chapter in Book/Report/Conference proceedingChapter

@inbook{e37e1c72e78b46d885708131030e6c20,
title = "Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer",
abstract = "Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Gu{\'e}rin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45{\%} rate of recurrence and 17{\%} of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.",
keywords = "Nonmuscle invasive bladder cancer, Progression, Recurrence, Risk factors",
author = "Park, {Jae Young}",
year = "2017",
month = "12",
day = "14",
doi = "10.1016/B978-0-12-809939-1.00013-8",
language = "English",
isbn = "9780128099391",
pages = "187--199",
booktitle = "Bladder Cancer",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer

AU - Park, Jae Young

PY - 2017/12/14

Y1 - 2017/12/14

N2 - Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Guérin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45% rate of recurrence and 17% of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.

AB - Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Guérin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45% rate of recurrence and 17% of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.

KW - Nonmuscle invasive bladder cancer

KW - Progression

KW - Recurrence

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85054748373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054748373&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-809939-1.00013-8

DO - 10.1016/B978-0-12-809939-1.00013-8

M3 - Chapter

AN - SCOPUS:85054748373

SN - 9780128099391

SP - 187

EP - 199

BT - Bladder Cancer

PB - Elsevier Inc.

ER -